13d
News-Medical.Net on MSNNew three-organ system offers an animal-free alternative for pharmacokinetics researchInnovative organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully ...
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...
The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...
The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, ...
5d
News-Medical.Net on MSNBreakthrough drug combination targets KRAS mutation in lung cancerA breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...
The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.
EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...
A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results